Enzymes in the Pharmaceutical Industry for β-Lactam Antibiotic Production
Authors:
- Raúl Rodriguez-HerreraRRRaúl Rodriguez-Herrera
- Luis Enrique Cobos PucLuis Enrique Cobos Puc
- Janeth Margarita Ventura SobrevillaJSJaneth Margarita Ventura Sobrevilla
- Diana LuqueDLDiana Luque
- Cesar S. Cardona-FelixCCCesar S. Cardona-Felix
- Cristóbal Noé Aguilar-GonzálezCristóbal Noé Aguilar-González
- Adriana C. Flores-GallegosAFAdriana C. Flores-Gallegos
- 31 August 2018
- book chapter
- Published by Elsevier
- p. 627-643
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Advances in the chemistry of ?-lactam and its medicinal applicationsTetrahedron, 2012
- An overview of enzymatic reagents for the removal of affinity tagsProtein Expression and Purification, 2011
- Carbapenems: Past, Present, and FutureAntimicrobial Agents and Chemotherapy, 2011
- Antagonism of Chemical Genetic Interaction Networks Resensitize MRSA to β-Lactam AntibioticsChemistry & Biology, 2011
- The future of the β-lactamsCurrent Opinion in Microbiology, 2010
- Antibiotics from microbes: converging to killCurrent Opinion in Microbiology, 2009
- Thermodynamically Controlled Synthesis of Amide Bonds Catalyzed by Highly Organic Solvent-Resistant Penicillin Acylase DerivativesBiotechnology Progress, 2008
- Comparative Review of the CarbapenemsDrugs, 2007
- Some special features of glyoxyl supports to immobilize proteinsEnzyme and Microbial Technology, 2005
- A GENERAL SYNTHESIS OF THE PENICILLINSJournal of the American Chemical Society, 1959